Affiliation:
1. Federal Research Center of Fundamental and Translational Medicine
2. Novosibirsk State Medical University of Minzdrav of Russia
Abstract
The aim of this study was to investigate the possibility of using apolipoprotein A-I (apo A-I) as a transport form of the green fluorescent protein (GFP) gene into rat hepatocytes.Material and methods. A culture of isolated rat hepatocytes was used as a model. Apo A-I conjugate with fluorescein isothiocyanate (FITC) was obtained by incubation of apo A-I protein with FITC in carbonate buffer pH 9.5 at a ratio of 12.5 μg FITC per 1 mg of protein. Plasmids for pE-GAG transfection with an integrated GFP gene were enriched in the promoter part with cis-elements of the CC(GCC)3-5 type to enhance complex formation with apo A-I. An inverted fluorescence microscope was used for visual analysis of cell fluorescence.Results and discussion. The paper presents evidence of FITC-labeled apo A-I penetration into the cytoplasm and nuclei of rat hepatocytes by receptor-mediated endocytosis. On this basis, it is proposed an attempt to use apo A-I as a means of targeted delivery of plasmid DNA with an integrated GFP gene into the cell. According to the results of fluorescence microscopy, the use of apo A-I as a plasmid DNA transfection agent led to the accumulation of the GFP protein in the cytoplasm of hepatocytes. No fluorescent protein was observed in the absence of apo A-I.Conclusions. The result obtained may indicate the delivery of the GFP gene to the nuclear apparatus of the cell, its expression and GFP protein synthesis.
Publisher
Institute of Cytology and Genetics, SB RAS
Subject
General Biochemistry, Genetics and Molecular Biology
Reference14 articles.
1. Kouraklis G. Gene therapy for cancer: From the laboratory to the patient. Dig. Dis. Sci. 2000;45(6):1045–1052. doi: 10.1023/a:1005592309466
2. Felgner P.L., Gadek T.R., Holm M., Roman R., Chan H.W., Wenz M., Northrop J.P., Ringold G.M., Danielsen M. Lipofection: A highly efficient, lipid-mediated DNA-transfection procedure. Proc. Natl. Acad. Sci. U.S.A. 1987;84(21):7413–7417. doi: 10.1073/pnas.84.21.7413
3. Balicki D., Beutler E. Gene therapy of human disease. Medicine (Baltimore). 2002;81(1):69–86. doi: 10.1097/00005792-200201000-00005
4. Jung H.J., Hwang D.S., Wei Q.D., Cha H.J. Carassius auratus – originated recombinant histone H1 C-terminal peptide as gene delivery material. Biotechnol. Prog. 2008;24(1):17–22. doi: 10.1021/bp070069b
5. Polyakov L.M., Panin L.E. High-density lipoprotein, and apolipoprotein A-I: a regulatory role and novel therapeutic strategies for the treatment atherosclerosis. Ateroskleroz = Atherosclerosis. 2013;9(1):42–53. [In Russian].